End-organ protection in cardiac surgery

Minerva Anestesiologica

Volumn 79, Issue 3, 2013, Pages 285-293

  De Somer, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Multiple organ failure

Indexed keywords

HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CAPILLARY DENSITY; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DETERIORATION; DISEASE PREDISPOSITION; HEART DISEASE; HEART INDEX; HEART OUTPUT; HEART SURGERY; HEMODILUTION; HUMAN; HYPERLACTATEMIA; HYPERTENSION; INFECTION; KIDNEY FAILURE; METABOLIC SYNDROME X; MICROEMBOLISM; REVIEW; RISK ASSESSMENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CARDIAC SURGICAL PROCEDURES; CORONARY CIRCULATION; EMBOLISM; EMBOLISM, AIR; HEART DISEASES; HEMODILUTION; HUMANS; OXYGEN INHALATION THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84878191257     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Nashef SA, Roques F, Sharpies LD, Nilsson J, Smith C, Goldstone AR et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734-44; discussion 44-5.
2. Roques E Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22; discussion 22-3.
3. Onorati F, Rubino AS, Cuda A, Fori D, Sica V, Santini F et al. Impact of endothelial activation on infective and inflammatory complications after cardiac surgery in type II diabetes mellitus. Int J Artif Organs 2011;34:469-80.
4. Angeloni E, Melina G, Benedetto U, Refice S, Capuano F, Roscitano A et al. Metabolic syndrome affects midterm outcome after coronary artery bypass grafting. Ann Thorac Surg 2012;93:537-44.
5. Coca SG, Jammalamadaka D, Sint K, Thiessen Philbrook H, Shlipak MG, Zappitelli M et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2012;143:495-502.
6. Caynak B, Bayramoglu Z, Onan B, Onan IS, Sagbas E, Sanisoglu I et al. The impact of non-dialysis-dependent renal dysfunction on outcome following cardiac surgery. Heart Surg Forum 2011;14:E214-20.
7. Tamura K, Arai H, Yoshizaki T. Long-term outcome of active infective endocarditis with renal insufficiency in cardiac surgery. Ann Thorac Cardiovasc Surg 2012;18:216-21.
8. Butler J, Baigrie RJ, Parker D, Chong JL, Shale DJ, Pillai R et al. Systemic inflammatory responses to cardiopulmonary bypass: a pilot study of the effects of pentoxifylline. Respir Med 1993;87:285-8. (Pubitemid 23194335)
9. Gu YJ, Schoen P, Tigchelaar I, Loef BG, Ebels T, Rankin AJ et al. Increased neutrophil priming and sensitization before commencing cardiopulmonary bypass in cardiac surgical patients. Ann Thorac Surg 2002;74:1173-9. (Pubitemid 35176742)
10. Franke A, Lante W, Fackeldey V, Becker HP, Thode C, Kuhlmann WD et al. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Ann Thorac Surg 2002;74:363-70; discussion 70-1.
11. Dinarello CA, Pomerantz BJ. Proinflammatory cytokines in heart disease. Blood Purif 2001;19:314-21. (Pubitemid 32217844)
12. Sanders J, Hawe E, Brull DJ, Hubbart C, Lowe GD, Rumley A et al. Higher IL-6 levels but not IL6 -174G>C or -572G>C genotype are associated with postoperative complication following coronary artery bypass graft (CABG) surgery. Atherosclerosis 2009;204:196-201.
13. Landis RC. Redefining the systemic inflammatory response. Semin Cardiothorac Vasc Anesth 2009;13:87-94.
14. Smith PK, Shernan SK, Chen JC, Carrier M, Verrier ED, Adams PX et al. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J Thorac Cardiovasc Surg 2011;142:89-98.
15. Clive Landis R, Murkin JM, Stump DA, Baker RA, Arrowsmith JE, De Somer F et al. Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum 2010;13:E116-23.
16. Landis RC, Arrowsmith JE, Baker RA, de Somer F, Dobkowski WB, Fisher G et al. Consensus statement: defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum 2008;11:E316-22.
17. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-8. (Pubitemid 36523666)
18. Vincent JL. Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 1997;25:372-4.
19. Weiss M, Huber-Lang M, Taenzer M, Traeger K, Altherr J, Kron M et al. Different patient case mix by applying the 2003 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions instead of the 1992 ACCP/SCCM sepsis definitions in surgical patients: a retrospective observational study. BMC Med Inform Decis Mak 2009;9:25.
20. Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med 2011;39:322-7.
21. Litmathe J, Boeken U, Bohlen G, Gursoy D, Sucker C, Feindt P. Systemic inflammatory response syndrome after extracorporeal circulation: a predictive algorithm for the patient at risk. Hellenic J Cardiol 2011;52:493-500.
22. Bouchard D, Carrier M, Demers P, Cartier R, Pellerin M, Perrault LP et al. Statin in combination with beta-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. Ann Thorac Surg 2011;91:654-9.
23. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 2006;333:1149.
24. Presta P, Rubino AS, Lucisano G, Serraino GF, Foti D, Gulletta E et al. Preoperative statins improve recovery of renal function but not by an anti-inflammatory effect: observational study in 69 elderly patients undergoing cardiac surgery. Int Urol Nephrol 2011;43:601-9.
25. Iakovis P, Anyfantakis ZA, Limas C, Kroupis C, Degiannis D, Cokkinos DV. Increased inflammatory response in patients with dilated cardiomyopathy is associated with dyslipidemia: Effects of statin therapy. Angiology 2011;62:55-61.
26. Cao L, Young N, Liu H, Silvestry S, Sun W, Zhao N et al. Preoperative aspirin use and outcomes in cardiac surgery patients. Ann Surg 2012;255:399-404.
27. Landis RC. Protease activated receptors: clinical relevance to hemostasis and inflammation. Hematol Oncol Clin North Am 2007;21:103-13. (Pubitemid 46164771)
28. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65. (Pubitemid 43145060)
29. Straub A, Azevedo R, Beierlein W, Wendel HP, Dietz K, Ziemer G. Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. Thromb Haemost 2005;94:115-22. (Pubitemid 40974715)
30. Straub A, Wendel HP, Azevedo R, Ziemer G. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation. Eur J Cardiothorac Surg 2005;27:617-21. (Pubitemid 40409733)
31. Barua A, Standen NB, Galinanes M. Modulation of the nitric oxide metabolism overcomes the unresponsiveness of the diabetic human myocardium to protection against ischemic injury. J Surg Res 2011;171:452-6.
32. Gianetti J, Del Sarto P, Bevilacqua S, Vassalle C, De Filippis R, Kacila M et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2004;127:44-50. (Pubitemid 38160464)
33. Hubert B, Troncy E, Gauvin D, Taha R, Pang D, Beauchamp G et al. Increased alveolar and plasma gelatinases activity during postpump syndrome: Inhibition by inhaled nitric oxide. J Cardiovasc Pharmacol 2006;48:71-8. (Pubitemid 44562945)
34. Troncy E, Hubert B, Pang D, Taha R, Gauvin D, Beauchamp G et al. Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extracorporeal circulation in a pig model. Nitric Oxide 2006;14:261-71.
35. Suleiman MS, Zacharowski K, Angelini GD. Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics. Br J Pharmacol 2008;153:21-33.
36. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engoren M, Durham SJ et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005;33:1749-56. (Pubitemid 41153700)
37. Karkouti K, Djaiani G, Borger MA, Beattie WS, Fedorko L, Wijeysundera D et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 2005;80:1381-7. (Pubitemid 41354124)
38. Hannan EL, Samadashvili Z, Lahey SJ, Culliford AT, Higgins RS, Jordan D et al. Predictors of postoperative hematocrit and association of hematocrit with adverse outcomes for coronary artery bypass graft surgery patients with cardiopulmonary bypass. J Card Surg 2010;25:638-46.
39. Montiglio F, Dor V, Lecompte J, Fourquet D, Negrel A, Dauvilliers GN. Cardiac surgery in adults and children without use of blood. Ann Thorac Cardiovasc Surg 1998;4:3-11.
40. Stamou SC, White T, Barnett S, Boyce SW, Corso PJ, Lefrak EA. Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses. Am J Cardiol 2006;98:1223-5. (Pubitemid 44584111)
41. Murphy GS, Hessel EA, 2nd, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesthesia and Analgesia 2009;108:1394-417.
42. Bartels C, Gerdes A, Babin-Ebell J, Beyersdorf F, Boeken U, Doenst T et al. Cardiopulmonary bypass: evidence or experience based? J Thorac Cardiovasc Surg 2002;124:20-7.
43. Ranucci M, Romitti F, Isgro G, Cotza M, Brozzi S, Boncilli A et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg 2005;80:2213-20. (Pubitemid 41718057)
44. Huang YC. Monitoring oxygen delivery in the critically ill. Chest 2005:128(5 Suppl 2):554S-60S.
45. von Heymann C, Sander M, Foer A, Heinemann A, Spiess B, Braun J et al. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome - a randomized controlled study [ISRCTN35655335]. Crit Care 2006;10:R58.
46. Mandak J, Brzek V, Svitek V, Dergel M, Chek JL, Volt M et al. Peripheral tissue oxygenation during standard CPB and miniaturized CPB (direct oxymetric tissue perfusion monitoring study). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 [Epub ahead of print].
47. Goldman D. Theoretical models or microvascular oxygen transport to tissue. Microcirculation 2008;15:795-811.
48. Atasever B, Boer C, Goedhart P, Biervliet J, Seyffert J, Speekenbrink R et al. Distinct alterations in sublingual microcirculatory blood flow and hemoglobin oxygenation in on-pump and off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2011;25:784-90.
49. Lonsky V, Svitek V, Brzek V, Kubicek J, Volt M, Horak M et al. Direct oxymetric peripheral tissue perfusion monitoring during open heart surgery with the use of cardiopulmonary bypass: preliminary experience. Perfusion 2011;26:510-5.
50. De Backer D, Dubois MJ, Schmartz D, Koch M, Ducart A, Barvais L et al. Microcirculatory alterations in cardiac surgery: effects of cardiopulmonary bypass and anesthesia. Ann Thorac Surg 2009;88:1396-403.
51. Cabrales P, Tsai AG. Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions. Am J Physiol Renal Physiol 2006;291:H2445-52.
52. Cabrales P, Tsai AG, Frangos JA, Intaglietta M. Role of endothelial nitric oxide in microvascular oxygen delivery and consumption. Free Radic Biol Med 2005;39:1229-37. (Pubitemid 41407715)
53. Cabrales P, Martini J, Intaglietta M, Tsai AG. Blood viscosity maintains microvascular conditions during normovolemic anemia independent of blood oxygen-carrying capacity. Am J Physiol Renal Physiol 2006;291:H581-90. (Pubitemid 44175063)
54. Egginton S. In vivo shear stress response. Biochem Soc Trans 2011;39:1633-8.
55. Stafford-Smith M, Grocott HP. Renal medullary hypoxia during experimental cardiopulmonary bypass: a pilot study. Perfusion 2005;20:53-8. (Pubitemid 40298236)
56. de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit Care 2011;15:R192.
57. Cossu AP, Suelzu S, Piu P, Orecchioni M, Bazzu G, Padua G et al. Do on- and off-pump coronary bypass surgery differently affect perioperative peripheral tissue metabolism? Minerva Anestesiol 2012;78:26-33.
58. Chakravarti SB, Mittnacht AJ, Katz JC, Nguyen K, Joashi U, Srivastava S. Multisite near-infrared spectroscopy predicts elevated blood lactate level in children after cardiac surgery. J Cardiothorac Vasc Anesth 2009;23:663-7.
59. Rifai L, Winters J, Friedman E, Silver MA. Initial description of cerebral oximetry measurement in heart failure patients. Congest Heart Fail 2012;18:85-90.
60. Vallee F, Vallet B, Mathe O, Parraguette J, Mari A, Silva S et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med 2008;34:2218-25.
61. Cuschieri J, Rivers EP, Donnino MW, Katilius M, Jacobsen G, Nguyen HB et al. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 2005;31:818-22. (Pubitemid 40897537)
62. Demers P, Elkouri S, Martineau R, Couturier A, Cartier R. Outcome with high blood lactate levels during cardiopulmonary bypass in adult cardiac operation. Ann Thorac Surg 2000;70:2082-6. (Pubitemid 32015312)
63. Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A et al. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. Chest 2003;123:1361-6. (Pubitemid 36549750)
64. Ranucci M, De Toffol B, Isgro G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care 2006;10:R167.
65. Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C etal. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med 2002;28:272-7. (Pubitemid 34230647)
66. Ranucci M, Isgro G, Romitti F, Mele S, Biagioli B, Giomarelli P. Anaerobic metabolism during cardiopulmonary bypass: predictive value of carbon dioxide derived parameters. Ann Thorac Surg 2006;81:2189-95. (Pubitemid 43775546)
67. Lund C, Sundet K, Tennoe B, Hol PK, Rein KA, Fosse E et al. Cerebral ischemic injury and cognitive impairment after off-pump and on-pump coronary artery bypass grafting surgery. Ann Thorac Surg 2005;80:2126-31. (Pubitemid 41718040)
68. Brooker RF, Brown WR, Moody DM, Hammon JW, Jr., Reboussin DM, Deal DD et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 1998;65:1651-5.
69. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001;344:395-402. (Pubitemid 32128671)
70. van Dijk D, Spoor M, Hijman R, Nathoe HM, Borst C, Jansen EW et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA 2007;297:701-8. (Pubitemid 46294559)
71. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO, Kozora E et al. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 2009;361:1827-37.
72. Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol 1990;28:477-86. (Pubitemid 20359153)
73. Challa VR, Moody DM, Troost BT. Brain embolic phenomena associated with cardiopulmonary bypass. J Neurol Sci 1993;117:224-31. (Pubitemid 23274672)
74. Jack T, Boehne M, Brent BE, Hoy L, Koditz H, Wessel A et al. In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Med 2012;38:1008-16.
75. Liu JF, Su ZK, Ding WX. Quantitation of particulate microemboli during cardiopulmonary bypass: experimental and clinical studies. Ann Thorac Surg 1992;54:1196-202.
76. Merkle F, Boettcher W, Schulz F, Kopitz M, Koster A, Hennig E et al. Reduction of microemboli count in the priming fluid of cardiopulmonary bypass circuits. J Extra Corpor Technol 2003;35:133-8. (Pubitemid 36927755)
77. Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-55. (Pubitemid 34535085)
78. De Somer F, Van Belleghem Y, Caes F, Francois K, Van Overbeke H, Arnout J et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002;123:951-8.
79. Philippou H, Davidson SJ, Mole MT, Pepper JR, Burman JF, Lane DA. Two-chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass: relationship to increased thrombin generation and heparin concentration. Arterioscler Thromb Vasc Biol 1999;19:248-54. (Pubitemid 29072736)
80. Dixon B, Santamaria J, Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 2005;128:229-36. (Pubitemid 40994478)
81. Bronden B, Dencker M, Allers M, Plaza I, Jonsson H. Differential distribution of lipid microemboli after cardiac surgery. J Thorac Cardiovasc Surg 2006;81:643-8. (Pubitemid 43120571)
82. Bronden B, Dencker M, Blomquist S, Plaza I, Allers M, Jonsson H. The kinetics of lipid micro-emboli during cardiac surgery studied in a porcine model. Scand Cardiovasc J 2008;42:411-6.
83. Engstrom K, Engstrom KG. Hazards with electrocautery-induced decomposition of fatty acids - in view of lipid embolization. Scand Cardiovasc J 2010;44:307-12.
84. Engstrom KG. The embolic potential of liquid fat in pericardial suction blood, and its elimination. Perfusion 2003;18(Suppl 1):69-74.
85. de Vries AJ, Gu YJ, van Oeveren W. The rationale for fat filtration during cardiac surgery. Perfusion 2002;17(Suppl):29-33. (Pubitemid 34467135)
86. de Vries AJ, Vermeijden WJ, Gu YJ, Hagenaars JA, van Oeveren W. Clinical efficacy and biocompatibility of three different leukocyte and fat removal filters during cardiac surgery. Artif Organs 2006;30:452-7. (Pubitemid 43824191)
87. Kincaid EH, Jones TJ, Stump DA, Brown WR, Moody DM, Deal DD et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg 2000;70:1296-300.
88. Jewell AE, Akowuah EF, Suvarna SK, Braidley P, Hopkinson D, Cooper G. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg 2003;23:633-6. (Pubitemid 36411895)
89. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996;335:1857-63.
90. Borger MA, Ivanov J, Weisel RD, Peniston CM, Mickleborough LL, Rambaldini G et al. Decreasing incidence of stroke during valvular surgery. Circulation 1998;98(19 Suppl):II137-43. (Pubitemid 28512180)
91. Orszulak TA, Schaff HV, Pluth JR, Danielson GK, Puga FJ, Ilstrup DM et al. The risk of stroke in the early postoperative period following mitral valve replacement. Eur J Cardiothorac Surg 1995;9:615-9 discuss 20.
92. Gong J, Larsson R, Ekdahl KN, Mollnes TE, Nilsson U, Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol 1996;16:222-9. (Pubitemid 26249187)
93. Barak M, Katz Y. Microbubbles: pathophysiology and clinical implications. Chest 2005;128:2918-32. (Pubitemid 41509431)
94. Muth CM, Shank ES. Gas embolism. N Engl J Med 2000;342:476-82. (Pubitemid 30100236)
95. Lindner JR, Ismail S, Spotnitz WD, Skyba DM, Jayaweera AR, Kaul S. Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. Circulation 1998;98:2187-94. (Pubitemid 28527479)
96. Jones TJ, Deal DD, Vernon JC, Blackburn N, Stump DA. How effective are cardiopulmonary bypass circuits at removing gaseous microemboli? J Extra Corpor Technol 2002;34:34-9. (Pubitemid 34211780)